Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹563 Cr₹475 Cr₹29 Cr₹-251 Cr₹-119 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹563 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹563 Cr
Mar2025₹475 Cr
Mar2024₹29 Cr
Mar2023₹-251 Cr
Mar2022₹-119 Cr

How is Net Cash Inflow / Outflow of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹563 Cr
18.65
Mar2025 ₹475 Cr
1,523.94
Mar2024 ₹29 Cr
Positive
Mar2023 ₹-251 Cr
Negative
Mar2022 ₹-119 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹43,009.8 Cr -0.1% -4.1% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,497.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹294,146.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,474.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,349.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,989.0 Cr 2% 6% -6.7% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-0.1%

-4.1%

-4.7%

SENSEX

7%

11.5%

-3.5%


You may also like the below Video Courses